Global Amebiasis Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Amebiasis is an infection of the intestine caused by a parasite Entamoeba Histolytica. Symptoms of this disease include loose stool, abdominal cramping, and stomach pain.
LPI (LP Information)' newest research report, the “Amebiasis Industry Forecast” looks at past sales and reviews total world Amebiasis sales in 2022, providing a comprehensive analysis by region and market sector of projected Amebiasis sales for 2023 through 2029. With Amebiasis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Amebiasis industry.
This Insight Report provides a comprehensive analysis of the global Amebiasis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Amebiasis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Amebiasis market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Amebiasis and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Amebiasis.
The global Amebiasis market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Amebiasis is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Amebiasis is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Amebiasis is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Amebiasis players cover Dr. Reddy’s Laboratories, Mission Pharmacal, Aceto Corporation, Mylan Pharmaceuticals, Impax Laboratories, Pfizer, Sanofi, Lupin Pharmaceuticals and Glenmark Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Amebiasis market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Amebiasis market?
What factors are driving Amebiasis market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Amebiasis market opportunities vary by end market size?
How does Amebiasis break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Amebiasis is an infection of the intestine caused by a parasite Entamoeba Histolytica. Symptoms of this disease include loose stool, abdominal cramping, and stomach pain.
LPI (LP Information)' newest research report, the “Amebiasis Industry Forecast” looks at past sales and reviews total world Amebiasis sales in 2022, providing a comprehensive analysis by region and market sector of projected Amebiasis sales for 2023 through 2029. With Amebiasis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Amebiasis industry.
This Insight Report provides a comprehensive analysis of the global Amebiasis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Amebiasis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Amebiasis market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Amebiasis and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Amebiasis.
The global Amebiasis market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Amebiasis is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Amebiasis is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Amebiasis is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Amebiasis players cover Dr. Reddy’s Laboratories, Mission Pharmacal, Aceto Corporation, Mylan Pharmaceuticals, Impax Laboratories, Pfizer, Sanofi, Lupin Pharmaceuticals and Glenmark Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Amebiasis market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Metronidazole
- Paromomycin
- Tinidazole
- Other
- Hospital
- Pharmacy
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Dr. Reddy’s Laboratories
- Mission Pharmacal
- Aceto Corporation
- Mylan Pharmaceuticals
- Impax Laboratories
- Pfizer
- Sanofi
- Lupin Pharmaceuticals
- Glenmark Pharmaceuticals
- Sun Pharmaceutical
- Heritage Pharmaceuticals
What is the 10-year outlook for the global Amebiasis market?
What factors are driving Amebiasis market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Amebiasis market opportunities vary by end market size?
How does Amebiasis break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Amebiasis Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Amebiasis by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Amebiasis by Country/Region, 2018, 2022 & 2029
2.2 Amebiasis Segment by Type
2.2.1 Metronidazole
2.2.2 Paromomycin
2.2.3 Tinidazole
2.2.4 Other
2.3 Amebiasis Sales by Type
2.3.1 Global Amebiasis Sales Market Share by Type (2018-2023)
2.3.2 Global Amebiasis Revenue and Market Share by Type (2018-2023)
2.3.3 Global Amebiasis Sale Price by Type (2018-2023)
2.4 Amebiasis Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.5 Amebiasis Sales by Application
2.5.1 Global Amebiasis Sale Market Share by Application (2018-2023)
2.5.2 Global Amebiasis Revenue and Market Share by Application (2018-2023)
2.5.3 Global Amebiasis Sale Price by Application (2018-2023)
3 GLOBAL AMEBIASIS BY COMPANY
3.1 Global Amebiasis Breakdown Data by Company
3.1.1 Global Amebiasis Annual Sales by Company (2018-2023)
3.1.2 Global Amebiasis Sales Market Share by Company (2018-2023)
3.2 Global Amebiasis Annual Revenue by Company (2018-2023)
3.2.1 Global Amebiasis Revenue by Company (2018-2023)
3.2.2 Global Amebiasis Revenue Market Share by Company (2018-2023)
3.3 Global Amebiasis Sale Price by Company
3.4 Key Manufacturers Amebiasis Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Amebiasis Product Location Distribution
3.4.2 Players Amebiasis Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR AMEBIASIS BY GEOGRAPHIC REGION
4.1 World Historic Amebiasis Market Size by Geographic Region (2018-2023)
4.1.1 Global Amebiasis Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Amebiasis Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Amebiasis Market Size by Country/Region (2018-2023)
4.2.1 Global Amebiasis Annual Sales by Country/Region (2018-2023)
4.2.2 Global Amebiasis Annual Revenue by Country/Region (2018-2023)
4.3 Americas Amebiasis Sales Growth
4.4 APAC Amebiasis Sales Growth
4.5 Europe Amebiasis Sales Growth
4.6 Middle East & Africa Amebiasis Sales Growth
5 AMERICAS
5.1 Americas Amebiasis Sales by Country
5.1.1 Americas Amebiasis Sales by Country (2018-2023)
5.1.2 Americas Amebiasis Revenue by Country (2018-2023)
5.2 Americas Amebiasis Sales by Type
5.3 Americas Amebiasis Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Amebiasis Sales by Region
6.1.1 APAC Amebiasis Sales by Region (2018-2023)
6.1.2 APAC Amebiasis Revenue by Region (2018-2023)
6.2 APAC Amebiasis Sales by Type
6.3 APAC Amebiasis Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Amebiasis by Country
7.1.1 Europe Amebiasis Sales by Country (2018-2023)
7.1.2 Europe Amebiasis Revenue by Country (2018-2023)
7.2 Europe Amebiasis Sales by Type
7.3 Europe Amebiasis Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Amebiasis by Country
8.1.1 Middle East & Africa Amebiasis Sales by Country (2018-2023)
8.1.2 Middle East & Africa Amebiasis Revenue by Country (2018-2023)
8.2 Middle East & Africa Amebiasis Sales by Type
8.3 Middle East & Africa Amebiasis Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Amebiasis
10.3 Manufacturing Process Analysis of Amebiasis
10.4 Industry Chain Structure of Amebiasis
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Amebiasis Distributors
11.3 Amebiasis Customer
12 WORLD FORECAST REVIEW FOR AMEBIASIS BY GEOGRAPHIC REGION
12.1 Global Amebiasis Market Size Forecast by Region
12.1.1 Global Amebiasis Forecast by Region (2024-2029)
12.1.2 Global Amebiasis Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Amebiasis Forecast by Type
12.7 Global Amebiasis Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Dr. Reddy’s Laboratories
13.1.1 Dr. Reddy’s Laboratories Company Information
13.1.2 Dr. Reddy’s Laboratories Amebiasis Product Portfolios and Specifications
13.1.3 Dr. Reddy’s Laboratories Amebiasis Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Dr. Reddy’s Laboratories Main Business Overview
13.1.5 Dr. Reddy’s Laboratories Latest Developments
13.2 Mission Pharmacal
13.2.1 Mission Pharmacal Company Information
13.2.2 Mission Pharmacal Amebiasis Product Portfolios and Specifications
13.2.3 Mission Pharmacal Amebiasis Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Mission Pharmacal Main Business Overview
13.2.5 Mission Pharmacal Latest Developments
13.3 Aceto Corporation
13.3.1 Aceto Corporation Company Information
13.3.2 Aceto Corporation Amebiasis Product Portfolios and Specifications
13.3.3 Aceto Corporation Amebiasis Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Aceto Corporation Main Business Overview
13.3.5 Aceto Corporation Latest Developments
13.4 Mylan Pharmaceuticals
13.4.1 Mylan Pharmaceuticals Company Information
13.4.2 Mylan Pharmaceuticals Amebiasis Product Portfolios and Specifications
13.4.3 Mylan Pharmaceuticals Amebiasis Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Mylan Pharmaceuticals Main Business Overview
13.4.5 Mylan Pharmaceuticals Latest Developments
13.5 Impax Laboratories
13.5.1 Impax Laboratories Company Information
13.5.2 Impax Laboratories Amebiasis Product Portfolios and Specifications
13.5.3 Impax Laboratories Amebiasis Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Impax Laboratories Main Business Overview
13.5.5 Impax Laboratories Latest Developments
13.6 Pfizer
13.6.1 Pfizer Company Information
13.6.2 Pfizer Amebiasis Product Portfolios and Specifications
13.6.3 Pfizer Amebiasis Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Pfizer Main Business Overview
13.6.5 Pfizer Latest Developments
13.7 Sanofi
13.7.1 Sanofi Company Information
13.7.2 Sanofi Amebiasis Product Portfolios and Specifications
13.7.3 Sanofi Amebiasis Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Sanofi Main Business Overview
13.7.5 Sanofi Latest Developments
13.8 Lupin Pharmaceuticals
13.8.1 Lupin Pharmaceuticals Company Information
13.8.2 Lupin Pharmaceuticals Amebiasis Product Portfolios and Specifications
13.8.3 Lupin Pharmaceuticals Amebiasis Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Lupin Pharmaceuticals Main Business Overview
13.8.5 Lupin Pharmaceuticals Latest Developments
13.9 Glenmark Pharmaceuticals
13.9.1 Glenmark Pharmaceuticals Company Information
13.9.2 Glenmark Pharmaceuticals Amebiasis Product Portfolios and Specifications
13.9.3 Glenmark Pharmaceuticals Amebiasis Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Glenmark Pharmaceuticals Main Business Overview
13.9.5 Glenmark Pharmaceuticals Latest Developments
13.10 Sun Pharmaceutical
13.10.1 Sun Pharmaceutical Company Information
13.10.2 Sun Pharmaceutical Amebiasis Product Portfolios and Specifications
13.10.3 Sun Pharmaceutical Amebiasis Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Sun Pharmaceutical Main Business Overview
13.10.5 Sun Pharmaceutical Latest Developments
13.11 Heritage Pharmaceuticals
13.11.1 Heritage Pharmaceuticals Company Information
13.11.2 Heritage Pharmaceuticals Amebiasis Product Portfolios and Specifications
13.11.3 Heritage Pharmaceuticals Amebiasis Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Heritage Pharmaceuticals Main Business Overview
13.11.5 Heritage Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Amebiasis Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Amebiasis by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Amebiasis by Country/Region, 2018, 2022 & 2029
2.2 Amebiasis Segment by Type
2.2.1 Metronidazole
2.2.2 Paromomycin
2.2.3 Tinidazole
2.2.4 Other
2.3 Amebiasis Sales by Type
2.3.1 Global Amebiasis Sales Market Share by Type (2018-2023)
2.3.2 Global Amebiasis Revenue and Market Share by Type (2018-2023)
2.3.3 Global Amebiasis Sale Price by Type (2018-2023)
2.4 Amebiasis Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.5 Amebiasis Sales by Application
2.5.1 Global Amebiasis Sale Market Share by Application (2018-2023)
2.5.2 Global Amebiasis Revenue and Market Share by Application (2018-2023)
2.5.3 Global Amebiasis Sale Price by Application (2018-2023)
3 GLOBAL AMEBIASIS BY COMPANY
3.1 Global Amebiasis Breakdown Data by Company
3.1.1 Global Amebiasis Annual Sales by Company (2018-2023)
3.1.2 Global Amebiasis Sales Market Share by Company (2018-2023)
3.2 Global Amebiasis Annual Revenue by Company (2018-2023)
3.2.1 Global Amebiasis Revenue by Company (2018-2023)
3.2.2 Global Amebiasis Revenue Market Share by Company (2018-2023)
3.3 Global Amebiasis Sale Price by Company
3.4 Key Manufacturers Amebiasis Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Amebiasis Product Location Distribution
3.4.2 Players Amebiasis Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR AMEBIASIS BY GEOGRAPHIC REGION
4.1 World Historic Amebiasis Market Size by Geographic Region (2018-2023)
4.1.1 Global Amebiasis Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Amebiasis Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Amebiasis Market Size by Country/Region (2018-2023)
4.2.1 Global Amebiasis Annual Sales by Country/Region (2018-2023)
4.2.2 Global Amebiasis Annual Revenue by Country/Region (2018-2023)
4.3 Americas Amebiasis Sales Growth
4.4 APAC Amebiasis Sales Growth
4.5 Europe Amebiasis Sales Growth
4.6 Middle East & Africa Amebiasis Sales Growth
5 AMERICAS
5.1 Americas Amebiasis Sales by Country
5.1.1 Americas Amebiasis Sales by Country (2018-2023)
5.1.2 Americas Amebiasis Revenue by Country (2018-2023)
5.2 Americas Amebiasis Sales by Type
5.3 Americas Amebiasis Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Amebiasis Sales by Region
6.1.1 APAC Amebiasis Sales by Region (2018-2023)
6.1.2 APAC Amebiasis Revenue by Region (2018-2023)
6.2 APAC Amebiasis Sales by Type
6.3 APAC Amebiasis Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Amebiasis by Country
7.1.1 Europe Amebiasis Sales by Country (2018-2023)
7.1.2 Europe Amebiasis Revenue by Country (2018-2023)
7.2 Europe Amebiasis Sales by Type
7.3 Europe Amebiasis Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Amebiasis by Country
8.1.1 Middle East & Africa Amebiasis Sales by Country (2018-2023)
8.1.2 Middle East & Africa Amebiasis Revenue by Country (2018-2023)
8.2 Middle East & Africa Amebiasis Sales by Type
8.3 Middle East & Africa Amebiasis Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Amebiasis
10.3 Manufacturing Process Analysis of Amebiasis
10.4 Industry Chain Structure of Amebiasis
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Amebiasis Distributors
11.3 Amebiasis Customer
12 WORLD FORECAST REVIEW FOR AMEBIASIS BY GEOGRAPHIC REGION
12.1 Global Amebiasis Market Size Forecast by Region
12.1.1 Global Amebiasis Forecast by Region (2024-2029)
12.1.2 Global Amebiasis Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Amebiasis Forecast by Type
12.7 Global Amebiasis Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Dr. Reddy’s Laboratories
13.1.1 Dr. Reddy’s Laboratories Company Information
13.1.2 Dr. Reddy’s Laboratories Amebiasis Product Portfolios and Specifications
13.1.3 Dr. Reddy’s Laboratories Amebiasis Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Dr. Reddy’s Laboratories Main Business Overview
13.1.5 Dr. Reddy’s Laboratories Latest Developments
13.2 Mission Pharmacal
13.2.1 Mission Pharmacal Company Information
13.2.2 Mission Pharmacal Amebiasis Product Portfolios and Specifications
13.2.3 Mission Pharmacal Amebiasis Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Mission Pharmacal Main Business Overview
13.2.5 Mission Pharmacal Latest Developments
13.3 Aceto Corporation
13.3.1 Aceto Corporation Company Information
13.3.2 Aceto Corporation Amebiasis Product Portfolios and Specifications
13.3.3 Aceto Corporation Amebiasis Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Aceto Corporation Main Business Overview
13.3.5 Aceto Corporation Latest Developments
13.4 Mylan Pharmaceuticals
13.4.1 Mylan Pharmaceuticals Company Information
13.4.2 Mylan Pharmaceuticals Amebiasis Product Portfolios and Specifications
13.4.3 Mylan Pharmaceuticals Amebiasis Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Mylan Pharmaceuticals Main Business Overview
13.4.5 Mylan Pharmaceuticals Latest Developments
13.5 Impax Laboratories
13.5.1 Impax Laboratories Company Information
13.5.2 Impax Laboratories Amebiasis Product Portfolios and Specifications
13.5.3 Impax Laboratories Amebiasis Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Impax Laboratories Main Business Overview
13.5.5 Impax Laboratories Latest Developments
13.6 Pfizer
13.6.1 Pfizer Company Information
13.6.2 Pfizer Amebiasis Product Portfolios and Specifications
13.6.3 Pfizer Amebiasis Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Pfizer Main Business Overview
13.6.5 Pfizer Latest Developments
13.7 Sanofi
13.7.1 Sanofi Company Information
13.7.2 Sanofi Amebiasis Product Portfolios and Specifications
13.7.3 Sanofi Amebiasis Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Sanofi Main Business Overview
13.7.5 Sanofi Latest Developments
13.8 Lupin Pharmaceuticals
13.8.1 Lupin Pharmaceuticals Company Information
13.8.2 Lupin Pharmaceuticals Amebiasis Product Portfolios and Specifications
13.8.3 Lupin Pharmaceuticals Amebiasis Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Lupin Pharmaceuticals Main Business Overview
13.8.5 Lupin Pharmaceuticals Latest Developments
13.9 Glenmark Pharmaceuticals
13.9.1 Glenmark Pharmaceuticals Company Information
13.9.2 Glenmark Pharmaceuticals Amebiasis Product Portfolios and Specifications
13.9.3 Glenmark Pharmaceuticals Amebiasis Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Glenmark Pharmaceuticals Main Business Overview
13.9.5 Glenmark Pharmaceuticals Latest Developments
13.10 Sun Pharmaceutical
13.10.1 Sun Pharmaceutical Company Information
13.10.2 Sun Pharmaceutical Amebiasis Product Portfolios and Specifications
13.10.3 Sun Pharmaceutical Amebiasis Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Sun Pharmaceutical Main Business Overview
13.10.5 Sun Pharmaceutical Latest Developments
13.11 Heritage Pharmaceuticals
13.11.1 Heritage Pharmaceuticals Company Information
13.11.2 Heritage Pharmaceuticals Amebiasis Product Portfolios and Specifications
13.11.3 Heritage Pharmaceuticals Amebiasis Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Heritage Pharmaceuticals Main Business Overview
13.11.5 Heritage Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Amebiasis Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Amebiasis Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Metronidazole
Table 4. Major Players of Paromomycin
Table 5. Major Players of Tinidazole
Table 6. Major Players of Other
Table 7. Global Amebiasis Sales by Type (2018-2023) & (K MT)
Table 8. Global Amebiasis Sales Market Share by Type (2018-2023)
Table 9. Global Amebiasis Revenue by Type (2018-2023) & ($ million)
Table 10. Global Amebiasis Revenue Market Share by Type (2018-2023)
Table 11. Global Amebiasis Sale Price by Type (2018-2023) & (USD/MT)
Table 12. Global Amebiasis Sales by Application (2018-2023) & (K MT)
Table 13. Global Amebiasis Sales Market Share by Application (2018-2023)
Table 14. Global Amebiasis Revenue by Application (2018-2023)
Table 15. Global Amebiasis Revenue Market Share by Application (2018-2023)
Table 16. Global Amebiasis Sale Price by Application (2018-2023) & (USD/MT)
Table 17. Global Amebiasis Sales by Company (2018-2023) & (K MT)
Table 18. Global Amebiasis Sales Market Share by Company (2018-2023)
Table 19. Global Amebiasis Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Amebiasis Revenue Market Share by Company (2018-2023)
Table 21. Global Amebiasis Sale Price by Company (2018-2023) & (USD/MT)
Table 22. Key Manufacturers Amebiasis Producing Area Distribution and Sales Area
Table 23. Players Amebiasis Products Offered
Table 24. Amebiasis Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Amebiasis Sales by Geographic Region (2018-2023) & (K MT)
Table 28. Global Amebiasis Sales Market Share Geographic Region (2018-2023)
Table 29. Global Amebiasis Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Amebiasis Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Amebiasis Sales by Country/Region (2018-2023) & (K MT)
Table 32. Global Amebiasis Sales Market Share by Country/Region (2018-2023)
Table 33. Global Amebiasis Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Amebiasis Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Amebiasis Sales by Country (2018-2023) & (K MT)
Table 36. Americas Amebiasis Sales Market Share by Country (2018-2023)
Table 37. Americas Amebiasis Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Amebiasis Revenue Market Share by Country (2018-2023)
Table 39. Americas Amebiasis Sales by Type (2018-2023) & (K MT)
Table 40. Americas Amebiasis Sales by Application (2018-2023) & (K MT)
Table 41. APAC Amebiasis Sales by Region (2018-2023) & (K MT)
Table 42. APAC Amebiasis Sales Market Share by Region (2018-2023)
Table 43. APAC Amebiasis Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Amebiasis Revenue Market Share by Region (2018-2023)
Table 45. APAC Amebiasis Sales by Type (2018-2023) & (K MT)
Table 46. APAC Amebiasis Sales by Application (2018-2023) & (K MT)
Table 47. Europe Amebiasis Sales by Country (2018-2023) & (K MT)
Table 48. Europe Amebiasis Sales Market Share by Country (2018-2023)
Table 49. Europe Amebiasis Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Amebiasis Revenue Market Share by Country (2018-2023)
Table 51. Europe Amebiasis Sales by Type (2018-2023) & (K MT)
Table 52. Europe Amebiasis Sales by Application (2018-2023) & (K MT)
Table 53. Middle East & Africa Amebiasis Sales by Country (2018-2023) & (K MT)
Table 54. Middle East & Africa Amebiasis Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Amebiasis Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Amebiasis Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Amebiasis Sales by Type (2018-2023) & (K MT)
Table 58. Middle East & Africa Amebiasis Sales by Application (2018-2023) & (K MT)
Table 59. Key Market Drivers & Growth Opportunities of Amebiasis
Table 60. Key Market Challenges & Risks of Amebiasis
Table 61. Key Industry Trends of Amebiasis
Table 62. Amebiasis Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Amebiasis Distributors List
Table 65. Amebiasis Customer List
Table 66. Global Amebiasis Sales Forecast by Region (2024-2029) & (K MT)
Table 67. Global Amebiasis Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Amebiasis Sales Forecast by Country (2024-2029) & (K MT)
Table 69. Americas Amebiasis Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Amebiasis Sales Forecast by Region (2024-2029) & (K MT)
Table 71. APAC Amebiasis Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Amebiasis Sales Forecast by Country (2024-2029) & (K MT)
Table 73. Europe Amebiasis Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Amebiasis Sales Forecast by Country (2024-2029) & (K MT)
Table 75. Middle East & Africa Amebiasis Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Amebiasis Sales Forecast by Type (2024-2029) & (K MT)
Table 77. Global Amebiasis Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Amebiasis Sales Forecast by Application (2024-2029) & (K MT)
Table 79. Global Amebiasis Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Dr. Reddy’s Laboratories Basic Information, Amebiasis Manufacturing Base, Sales Area and Its Competitors
Table 81. Dr. Reddy’s Laboratories Amebiasis Product Portfolios and Specifications
Table 82. Dr. Reddy’s Laboratories Amebiasis Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 83. Dr. Reddy’s Laboratories Main Business
Table 84. Dr. Reddy’s Laboratories Latest Developments
Table 85. Mission Pharmacal Basic Information, Amebiasis Manufacturing Base, Sales Area and Its Competitors
Table 86. Mission Pharmacal Amebiasis Product Portfolios and Specifications
Table 87. Mission Pharmacal Amebiasis Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 88. Mission Pharmacal Main Business
Table 89. Mission Pharmacal Latest Developments
Table 90. Aceto Corporation Basic Information, Amebiasis Manufacturing Base, Sales Area and Its Competitors
Table 91. Aceto Corporation Amebiasis Product Portfolios and Specifications
Table 92. Aceto Corporation Amebiasis Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 93. Aceto Corporation Main Business
Table 94. Aceto Corporation Latest Developments
Table 95. Mylan Pharmaceuticals Basic Information, Amebiasis Manufacturing Base, Sales Area and Its Competitors
Table 96. Mylan Pharmaceuticals Amebiasis Product Portfolios and Specifications
Table 97. Mylan Pharmaceuticals Amebiasis Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 98. Mylan Pharmaceuticals Main Business
Table 99. Mylan Pharmaceuticals Latest Developments
Table 100. Impax Laboratories Basic Information, Amebiasis Manufacturing Base, Sales Area and Its Competitors
Table 101. Impax Laboratories Amebiasis Product Portfolios and Specifications
Table 102. Impax Laboratories Amebiasis Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 103. Impax Laboratories Main Business
Table 104. Impax Laboratories Latest Developments
Table 105. Pfizer Basic Information, Amebiasis Manufacturing Base, Sales Area and Its Competitors
Table 106. Pfizer Amebiasis Product Portfolios and Specifications
Table 107. Pfizer Amebiasis Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 108. Pfizer Main Business
Table 109. Pfizer Latest Developments
Table 110. Sanofi Basic Information, Amebiasis Manufacturing Base, Sales Area and Its Competitors
Table 111. Sanofi Amebiasis Product Portfolios and Specifications
Table 112. Sanofi Amebiasis Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 113. Sanofi Main Business
Table 114. Sanofi Latest Developments
Table 115. Lupin Pharmaceuticals Basic Information, Amebiasis Manufacturing Base, Sales Area and Its Competitors
Table 116. Lupin Pharmaceuticals Amebiasis Product Portfolios and Specifications
Table 117. Lupin Pharmaceuticals Amebiasis Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 118. Lupin Pharmaceuticals Main Business
Table 119. Lupin Pharmaceuticals Latest Developments
Table 120. Glenmark Pharmaceuticals Basic Information, Amebiasis Manufacturing Base, Sales Area and Its Competitors
Table 121. Glenmark Pharmaceuticals Amebiasis Product Portfolios and Specifications
Table 122. Glenmark Pharmaceuticals Amebiasis Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 123. Glenmark Pharmaceuticals Main Business
Table 124. Glenmark Pharmaceuticals Latest Developments
Table 125. Sun Pharmaceutical Basic Information, Amebiasis Manufacturing Base, Sales Area and Its Competitors
Table 126. Sun Pharmaceutical Amebiasis Product Portfolios and Specifications
Table 127. Sun Pharmaceutical Amebiasis Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 128. Sun Pharmaceutical Main Business
Table 129. Sun Pharmaceutical Latest Developments
Table 130. Heritage Pharmaceuticals Basic Information, Amebiasis Manufacturing Base, Sales Area and Its Competitors
Table 131. Heritage Pharmaceuticals Amebiasis Product Portfolios and Specifications
Table 132. Heritage Pharmaceuticals Amebiasis Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 133. Heritage Pharmaceuticals Main Business
Table 134. Heritage Pharmaceuticals Latest Developments
Table 1. Amebiasis Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Amebiasis Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Metronidazole
Table 4. Major Players of Paromomycin
Table 5. Major Players of Tinidazole
Table 6. Major Players of Other
Table 7. Global Amebiasis Sales by Type (2018-2023) & (K MT)
Table 8. Global Amebiasis Sales Market Share by Type (2018-2023)
Table 9. Global Amebiasis Revenue by Type (2018-2023) & ($ million)
Table 10. Global Amebiasis Revenue Market Share by Type (2018-2023)
Table 11. Global Amebiasis Sale Price by Type (2018-2023) & (USD/MT)
Table 12. Global Amebiasis Sales by Application (2018-2023) & (K MT)
Table 13. Global Amebiasis Sales Market Share by Application (2018-2023)
Table 14. Global Amebiasis Revenue by Application (2018-2023)
Table 15. Global Amebiasis Revenue Market Share by Application (2018-2023)
Table 16. Global Amebiasis Sale Price by Application (2018-2023) & (USD/MT)
Table 17. Global Amebiasis Sales by Company (2018-2023) & (K MT)
Table 18. Global Amebiasis Sales Market Share by Company (2018-2023)
Table 19. Global Amebiasis Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Amebiasis Revenue Market Share by Company (2018-2023)
Table 21. Global Amebiasis Sale Price by Company (2018-2023) & (USD/MT)
Table 22. Key Manufacturers Amebiasis Producing Area Distribution and Sales Area
Table 23. Players Amebiasis Products Offered
Table 24. Amebiasis Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Amebiasis Sales by Geographic Region (2018-2023) & (K MT)
Table 28. Global Amebiasis Sales Market Share Geographic Region (2018-2023)
Table 29. Global Amebiasis Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Amebiasis Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Amebiasis Sales by Country/Region (2018-2023) & (K MT)
Table 32. Global Amebiasis Sales Market Share by Country/Region (2018-2023)
Table 33. Global Amebiasis Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Amebiasis Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Amebiasis Sales by Country (2018-2023) & (K MT)
Table 36. Americas Amebiasis Sales Market Share by Country (2018-2023)
Table 37. Americas Amebiasis Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Amebiasis Revenue Market Share by Country (2018-2023)
Table 39. Americas Amebiasis Sales by Type (2018-2023) & (K MT)
Table 40. Americas Amebiasis Sales by Application (2018-2023) & (K MT)
Table 41. APAC Amebiasis Sales by Region (2018-2023) & (K MT)
Table 42. APAC Amebiasis Sales Market Share by Region (2018-2023)
Table 43. APAC Amebiasis Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Amebiasis Revenue Market Share by Region (2018-2023)
Table 45. APAC Amebiasis Sales by Type (2018-2023) & (K MT)
Table 46. APAC Amebiasis Sales by Application (2018-2023) & (K MT)
Table 47. Europe Amebiasis Sales by Country (2018-2023) & (K MT)
Table 48. Europe Amebiasis Sales Market Share by Country (2018-2023)
Table 49. Europe Amebiasis Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Amebiasis Revenue Market Share by Country (2018-2023)
Table 51. Europe Amebiasis Sales by Type (2018-2023) & (K MT)
Table 52. Europe Amebiasis Sales by Application (2018-2023) & (K MT)
Table 53. Middle East & Africa Amebiasis Sales by Country (2018-2023) & (K MT)
Table 54. Middle East & Africa Amebiasis Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Amebiasis Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Amebiasis Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Amebiasis Sales by Type (2018-2023) & (K MT)
Table 58. Middle East & Africa Amebiasis Sales by Application (2018-2023) & (K MT)
Table 59. Key Market Drivers & Growth Opportunities of Amebiasis
Table 60. Key Market Challenges & Risks of Amebiasis
Table 61. Key Industry Trends of Amebiasis
Table 62. Amebiasis Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Amebiasis Distributors List
Table 65. Amebiasis Customer List
Table 66. Global Amebiasis Sales Forecast by Region (2024-2029) & (K MT)
Table 67. Global Amebiasis Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Amebiasis Sales Forecast by Country (2024-2029) & (K MT)
Table 69. Americas Amebiasis Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Amebiasis Sales Forecast by Region (2024-2029) & (K MT)
Table 71. APAC Amebiasis Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Amebiasis Sales Forecast by Country (2024-2029) & (K MT)
Table 73. Europe Amebiasis Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Amebiasis Sales Forecast by Country (2024-2029) & (K MT)
Table 75. Middle East & Africa Amebiasis Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Amebiasis Sales Forecast by Type (2024-2029) & (K MT)
Table 77. Global Amebiasis Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Amebiasis Sales Forecast by Application (2024-2029) & (K MT)
Table 79. Global Amebiasis Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Dr. Reddy’s Laboratories Basic Information, Amebiasis Manufacturing Base, Sales Area and Its Competitors
Table 81. Dr. Reddy’s Laboratories Amebiasis Product Portfolios and Specifications
Table 82. Dr. Reddy’s Laboratories Amebiasis Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 83. Dr. Reddy’s Laboratories Main Business
Table 84. Dr. Reddy’s Laboratories Latest Developments
Table 85. Mission Pharmacal Basic Information, Amebiasis Manufacturing Base, Sales Area and Its Competitors
Table 86. Mission Pharmacal Amebiasis Product Portfolios and Specifications
Table 87. Mission Pharmacal Amebiasis Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 88. Mission Pharmacal Main Business
Table 89. Mission Pharmacal Latest Developments
Table 90. Aceto Corporation Basic Information, Amebiasis Manufacturing Base, Sales Area and Its Competitors
Table 91. Aceto Corporation Amebiasis Product Portfolios and Specifications
Table 92. Aceto Corporation Amebiasis Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 93. Aceto Corporation Main Business
Table 94. Aceto Corporation Latest Developments
Table 95. Mylan Pharmaceuticals Basic Information, Amebiasis Manufacturing Base, Sales Area and Its Competitors
Table 96. Mylan Pharmaceuticals Amebiasis Product Portfolios and Specifications
Table 97. Mylan Pharmaceuticals Amebiasis Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 98. Mylan Pharmaceuticals Main Business
Table 99. Mylan Pharmaceuticals Latest Developments
Table 100. Impax Laboratories Basic Information, Amebiasis Manufacturing Base, Sales Area and Its Competitors
Table 101. Impax Laboratories Amebiasis Product Portfolios and Specifications
Table 102. Impax Laboratories Amebiasis Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 103. Impax Laboratories Main Business
Table 104. Impax Laboratories Latest Developments
Table 105. Pfizer Basic Information, Amebiasis Manufacturing Base, Sales Area and Its Competitors
Table 106. Pfizer Amebiasis Product Portfolios and Specifications
Table 107. Pfizer Amebiasis Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 108. Pfizer Main Business
Table 109. Pfizer Latest Developments
Table 110. Sanofi Basic Information, Amebiasis Manufacturing Base, Sales Area and Its Competitors
Table 111. Sanofi Amebiasis Product Portfolios and Specifications
Table 112. Sanofi Amebiasis Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 113. Sanofi Main Business
Table 114. Sanofi Latest Developments
Table 115. Lupin Pharmaceuticals Basic Information, Amebiasis Manufacturing Base, Sales Area and Its Competitors
Table 116. Lupin Pharmaceuticals Amebiasis Product Portfolios and Specifications
Table 117. Lupin Pharmaceuticals Amebiasis Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 118. Lupin Pharmaceuticals Main Business
Table 119. Lupin Pharmaceuticals Latest Developments
Table 120. Glenmark Pharmaceuticals Basic Information, Amebiasis Manufacturing Base, Sales Area and Its Competitors
Table 121. Glenmark Pharmaceuticals Amebiasis Product Portfolios and Specifications
Table 122. Glenmark Pharmaceuticals Amebiasis Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 123. Glenmark Pharmaceuticals Main Business
Table 124. Glenmark Pharmaceuticals Latest Developments
Table 125. Sun Pharmaceutical Basic Information, Amebiasis Manufacturing Base, Sales Area and Its Competitors
Table 126. Sun Pharmaceutical Amebiasis Product Portfolios and Specifications
Table 127. Sun Pharmaceutical Amebiasis Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 128. Sun Pharmaceutical Main Business
Table 129. Sun Pharmaceutical Latest Developments
Table 130. Heritage Pharmaceuticals Basic Information, Amebiasis Manufacturing Base, Sales Area and Its Competitors
Table 131. Heritage Pharmaceuticals Amebiasis Product Portfolios and Specifications
Table 132. Heritage Pharmaceuticals Amebiasis Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 133. Heritage Pharmaceuticals Main Business
Table 134. Heritage Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Amebiasis
Figure 2. Amebiasis Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Amebiasis Sales Growth Rate 2018-2029 (K MT)
Figure 7. Global Amebiasis Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Amebiasis Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Metronidazole
Figure 10. Product Picture of Paromomycin
Figure 11. Product Picture of Tinidazole
Figure 12. Product Picture of Other
Figure 13. Global Amebiasis Sales Market Share by Type in 2022
Figure 14. Global Amebiasis Revenue Market Share by Type (2018-2023)
Figure 15. Amebiasis Consumed in Hospital
Figure 16. Global Amebiasis Market: Hospital (2018-2023) & (K MT)
Figure 17. Amebiasis Consumed in Pharmacy
Figure 18. Global Amebiasis Market: Pharmacy (2018-2023) & (K MT)
Figure 19. Global Amebiasis Sales Market Share by Application (2022)
Figure 20. Global Amebiasis Revenue Market Share by Application in 2022
Figure 21. Amebiasis Sales Market by Company in 2022 (K MT)
Figure 22. Global Amebiasis Sales Market Share by Company in 2022
Figure 23. Amebiasis Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Amebiasis Revenue Market Share by Company in 2022
Figure 25. Global Amebiasis Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Amebiasis Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Amebiasis Sales 2018-2023 (K MT)
Figure 28. Americas Amebiasis Revenue 2018-2023 ($ Millions)
Figure 29. APAC Amebiasis Sales 2018-2023 (K MT)
Figure 30. APAC Amebiasis Revenue 2018-2023 ($ Millions)
Figure 31. Europe Amebiasis Sales 2018-2023 (K MT)
Figure 32. Europe Amebiasis Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Amebiasis Sales 2018-2023 (K MT)
Figure 34. Middle East & Africa Amebiasis Revenue 2018-2023 ($ Millions)
Figure 35. Americas Amebiasis Sales Market Share by Country in 2022
Figure 36. Americas Amebiasis Revenue Market Share by Country in 2022
Figure 37. Americas Amebiasis Sales Market Share by Type (2018-2023)
Figure 38. Americas Amebiasis Sales Market Share by Application (2018-2023)
Figure 39. United States Amebiasis Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Amebiasis Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Amebiasis Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Amebiasis Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Amebiasis Sales Market Share by Region in 2022
Figure 44. APAC Amebiasis Revenue Market Share by Regions in 2022
Figure 45. APAC Amebiasis Sales Market Share by Type (2018-2023)
Figure 46. APAC Amebiasis Sales Market Share by Application (2018-2023)
Figure 47. China Amebiasis Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Amebiasis Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Amebiasis Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Amebiasis Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Amebiasis Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Amebiasis Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Amebiasis Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Amebiasis Sales Market Share by Country in 2022
Figure 55. Europe Amebiasis Revenue Market Share by Country in 2022
Figure 56. Europe Amebiasis Sales Market Share by Type (2018-2023)
Figure 57. Europe Amebiasis Sales Market Share by Application (2018-2023)
Figure 58. Germany Amebiasis Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Amebiasis Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Amebiasis Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Amebiasis Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Amebiasis Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Amebiasis Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Amebiasis Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Amebiasis Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Amebiasis Sales Market Share by Application (2018-2023)
Figure 67. Egypt Amebiasis Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Amebiasis Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Amebiasis Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Amebiasis Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Amebiasis Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Amebiasis in 2022
Figure 73. Manufacturing Process Analysis of Amebiasis
Figure 74. Industry Chain Structure of Amebiasis
Figure 75. Channels of Distribution
Figure 76. Global Amebiasis Sales Market Forecast by Region (2024-2029)
Figure 77. Global Amebiasis Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Amebiasis Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Amebiasis Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Amebiasis Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Amebiasis Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Amebiasis
Figure 2. Amebiasis Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Amebiasis Sales Growth Rate 2018-2029 (K MT)
Figure 7. Global Amebiasis Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Amebiasis Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Metronidazole
Figure 10. Product Picture of Paromomycin
Figure 11. Product Picture of Tinidazole
Figure 12. Product Picture of Other
Figure 13. Global Amebiasis Sales Market Share by Type in 2022
Figure 14. Global Amebiasis Revenue Market Share by Type (2018-2023)
Figure 15. Amebiasis Consumed in Hospital
Figure 16. Global Amebiasis Market: Hospital (2018-2023) & (K MT)
Figure 17. Amebiasis Consumed in Pharmacy
Figure 18. Global Amebiasis Market: Pharmacy (2018-2023) & (K MT)
Figure 19. Global Amebiasis Sales Market Share by Application (2022)
Figure 20. Global Amebiasis Revenue Market Share by Application in 2022
Figure 21. Amebiasis Sales Market by Company in 2022 (K MT)
Figure 22. Global Amebiasis Sales Market Share by Company in 2022
Figure 23. Amebiasis Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Amebiasis Revenue Market Share by Company in 2022
Figure 25. Global Amebiasis Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Amebiasis Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Amebiasis Sales 2018-2023 (K MT)
Figure 28. Americas Amebiasis Revenue 2018-2023 ($ Millions)
Figure 29. APAC Amebiasis Sales 2018-2023 (K MT)
Figure 30. APAC Amebiasis Revenue 2018-2023 ($ Millions)
Figure 31. Europe Amebiasis Sales 2018-2023 (K MT)
Figure 32. Europe Amebiasis Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Amebiasis Sales 2018-2023 (K MT)
Figure 34. Middle East & Africa Amebiasis Revenue 2018-2023 ($ Millions)
Figure 35. Americas Amebiasis Sales Market Share by Country in 2022
Figure 36. Americas Amebiasis Revenue Market Share by Country in 2022
Figure 37. Americas Amebiasis Sales Market Share by Type (2018-2023)
Figure 38. Americas Amebiasis Sales Market Share by Application (2018-2023)
Figure 39. United States Amebiasis Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Amebiasis Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Amebiasis Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Amebiasis Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Amebiasis Sales Market Share by Region in 2022
Figure 44. APAC Amebiasis Revenue Market Share by Regions in 2022
Figure 45. APAC Amebiasis Sales Market Share by Type (2018-2023)
Figure 46. APAC Amebiasis Sales Market Share by Application (2018-2023)
Figure 47. China Amebiasis Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Amebiasis Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Amebiasis Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Amebiasis Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Amebiasis Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Amebiasis Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Amebiasis Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Amebiasis Sales Market Share by Country in 2022
Figure 55. Europe Amebiasis Revenue Market Share by Country in 2022
Figure 56. Europe Amebiasis Sales Market Share by Type (2018-2023)
Figure 57. Europe Amebiasis Sales Market Share by Application (2018-2023)
Figure 58. Germany Amebiasis Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Amebiasis Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Amebiasis Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Amebiasis Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Amebiasis Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Amebiasis Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Amebiasis Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Amebiasis Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Amebiasis Sales Market Share by Application (2018-2023)
Figure 67. Egypt Amebiasis Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Amebiasis Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Amebiasis Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Amebiasis Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Amebiasis Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Amebiasis in 2022
Figure 73. Manufacturing Process Analysis of Amebiasis
Figure 74. Industry Chain Structure of Amebiasis
Figure 75. Channels of Distribution
Figure 76. Global Amebiasis Sales Market Forecast by Region (2024-2029)
Figure 77. Global Amebiasis Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Amebiasis Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Amebiasis Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Amebiasis Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Amebiasis Revenue Market Share Forecast by Application (2024-2029)
